10x Genomics (TXG) Revenue & Revenue Breakdown
10x Genomics Revenue Highlights
Latest Revenue (Y)
$642.82M
Latest Revenue (Q)
$151.04M
Main Segment (Y)
Product And Service Revenue
Main Geography (Y)
Americas
10x Genomics Revenue by Period
10x Genomics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $642.82M | 5.25% |
| 2024-12-31 | $610.78M | -1.28% |
| 2023-12-31 | $618.73M | 19.81% |
| 2022-12-31 | $516.41M | 5.28% |
| 2021-12-31 | $490.49M | 64.13% |
| 2020-12-31 | $298.85M | 21.53% |
| 2019-12-31 | $245.89M | 68.06% |
| 2018-12-31 | $146.31M | 105.83% |
| 2017-12-31 | $71.08M | - |
10x Genomics generated $642.82M in revenue during NA 2025, up 5.25% compared to the previous quarter, and up 215.10% compared to the same period a year ago.
10x Genomics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-06-30 | $151.04M | 0.13% |
| 2026-03-31 | $150.84M | -9.15% |
| 2025-12-31 | $166.03M | 11.43% |
| 2025-09-30 | $149.00M | -13.83% |
| 2025-06-30 | $172.91M | 11.64% |
| 2025-03-31 | $154.88M | -6.14% |
| 2024-12-31 | $165.02M | 8.81% |
| 2024-09-30 | $151.65M | -0.95% |
| 2024-06-30 | $153.10M | 8.58% |
| 2024-03-31 | $141.01M | -23.36% |
| 2023-12-31 | $183.98M | 19.74% |
| 2023-09-30 | $153.64M | 4.65% |
| 2023-06-30 | $146.82M | 9.33% |
| 2023-03-31 | $134.28M | -14.05% |
| 2022-12-31 | $156.23M | 19.20% |
| 2022-09-30 | $131.07M | 14.36% |
| 2022-06-30 | $114.61M | 0.10% |
| 2022-03-31 | $114.50M | -20.23% |
| 2021-12-31 | $143.53M | 14.55% |
| 2021-09-30 | $125.30M | 8.16% |
| 2021-06-30 | $115.84M | 9.47% |
| 2021-03-31 | $105.82M | -5.70% |
| 2020-12-31 | $112.22M | 56.26% |
| 2020-09-30 | $71.82M | 67.39% |
| 2020-06-30 | $42.91M | -40.33% |
| 2020-03-31 | $71.91M | -4.49% |
| 2019-12-31 | $75.29M | 23.01% |
| 2019-09-30 | $61.21M | 9.65% |
| 2019-06-30 | $55.82M | 4.18% |
| 2019-03-31 | $53.58M | 5.98% |
| 2018-12-31 | $50.55M | 38.10% |
| 2018-09-30 | $36.61M | 15.32% |
| 2018-06-30 | $31.74M | 7.33% |
| 2018-03-31 | $29.58M | - |
10x Genomics generated $151.04M in revenue during Q2 2026, up 0.13% compared to the previous quarter, and up 97.52% compared to the same period a year ago.
10x Genomics Revenue Breakdown
10x Genomics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Service | $32.73M | $24.64M | $15.70M | $8.43M | $7.28M |
| Product And Service Revenue | $596.69M | - | - | - | - |
| Consumables | $507.18M | $493.43M | $479.55M | $435.59M | $418.74M |
| Instruments | $56.78M | $92.72M | $123.47M | - | - |
| Licensing And Royalty Revenue | $46.13M | - | - | - | - |
| Instuments | - | - | - | $72.40M | $64.47M |
10x Genomics's latest annual revenue breakdown by segment (product or service), as of Dec 25: Product And Service Revenue (48.14%), Consumables (40.92%), Instruments (4.58%), Licensing And Royalty Revenue (3.72%), and Service (2.64%).
Quarterly Revenue by Product
| Product/Service | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product And Service Revenue | $149.09M | $149.90M | $165.69M | $148.02M | $145.16M | $137.82M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Licensing And Royalty Revenue | $1.94M | $947.00K | $341.00K | $983.00K | $27.75M | $17.06M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Service | $10.68M | $8.83M | $8.47M | $8.13M | $8.47M | $7.65M | $13.03M | $6.39M | $5.22M | $5.27M | $4.33M | $3.38M | $2.73M | $2.30M | $2.07M | $1.94M | $2.12M | $1.78M | $2.06M | $1.82M |
| Instruments | $7.66M | $11.26M | $15.47M | $12.00M | $14.50M | $14.81M | $48.21M | $19.06M | $25.45M | $38.40M | $34.94M | $30.95M | $19.18M | $20.90M | $14.74M | $14.43M | $17.12M | $16.88M | - | - |
| Consumables | $130.75M | $129.80M | $141.75M | $127.89M | $122.19M | $115.36M | $256.89M | $126.20M | $110.33M | $140.31M | $114.37M | $112.49M | $112.38M | $131.60M | $108.11M | $97.93M | $97.95M | $122.40M | $106.12M | $97.15M |
10x Genomics's latest quarterly revenue breakdown by segment (product or service), as of Jun 26: Product And Service Revenue (49.68%), Consumables (43.57%), Service (3.56%), Instruments (2.55%), and Licensing And Royalty Revenue (0.65%).
10x Genomics Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Asia-Pacific, Excluding China | $52.07M | $45.96M | $52.29M | - | - |
| UNITED STATES | $346.51M | $334.32M | $360.09M | $284.99M | $258.27M |
| EMEA | $161.72M | $159.76M | $142.28M | $117.07M | $108.49M |
| Americas | $358.77M | $347.76M | $373.19M | - | - |
| CHINA | $70.26M | $57.30M | $50.97M | $59.56M | $74.92M |
| Asia Pacific | - | $103.26M | $103.26M | $46.00M | $42.09M |
| Americas, Excluding United States | - | $13.45M | $13.10M | - | - |
| North America, Excluding United States | - | - | - | $8.79M | $6.71M |
10x Genomics's latest annual revenue breakdown by geography, as of Dec 25: Americas (36.26%), UNITED STATES (35.02%), EMEA (16.35%), CHINA (7.10%), and Asia-Pacific, Excluding China (5.26%).
Quarterly Revenue by Country
| Country | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia-Pacific, Excluding China | $11.07M | $18.05M | $15.37M | $12.32M | $8.85M | $15.54M | $22.28M | $10.95M | $12.73M | $17.80M | $10.18M | $11.28M | $13.04M | $9.79M | $9.03M | $13.52M | $10.19M | $8.43M | - | - |
| CHINA | $14.97M | $15.84M | $15.02M | $15.19M | $23.17M | $16.88M | $28.35M | $15.03M | $13.92M | $11.75M | $12.43M | $12.76M | $14.03M | $13.94M | $15.77M | $9.09M | $20.76M | $19.35M | $19.06M | $12.87M |
| EMEA | $39.97M | $36.85M | $53.46M | $41.62M | $34.73M | $31.89M | $87.19M | $37.85M | $34.72M | $50.59M | $32.02M | $31.25M | $28.42M | $43.00M | $27.93M | $25.61M | $20.53M | $34.73M | $25.82M | $28.77M |
| UNITED STATES | $82.11M | $76.69M | $269.27M | $77.25M | $103.49M | $86.82M | $173.96M | $84.72M | $75.64M | $99.32M | $96.09M | $88.39M | $76.28M | $82.83M | $75.34M | $69.37M | $57.44M | - | - | - |
| Americas | $85.03M | $80.10M | $82.17M | $79.87M | $106.16M | $90.57M | $180.31M | $87.82M | $79.63M | $103.84M | $99.01M | $91.54M | $78.80M | - | - | - | - | - | - | - |
| Asia Pacific | - | - | - | - | $32.02M | $32.42M | $50.62M | $25.98M | $26.66M | $29.55M | $22.61M | $24.03M | $27.07M | - | - | - | - | - | - | - |
| Americas, Excluding United States | - | - | - | - | $2.67M | $3.75M | $6.36M | $3.10M | $3.99M | $4.52M | $2.92M | $3.15M | $2.52M | - | - | - | - | - | - | - |
| North America, Excluding United States | - | - | - | - | - | - | - | - | - | - | - | - | - | $2.79M | $2.24M | $1.51M | $2.25M | - | - | - |
| North America | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $70.23M | $65.77M |
10x Genomics's latest quarterly revenue breakdown by geography, as of Jun 26: Americas (36.47%), UNITED STATES (35.22%), EMEA (17.14%), CHINA (6.42%), and Asia-Pacific, Excluding China (4.75%).
10x Genomics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| TDOC | Teladoc Health | $2.53B | $606.93M |
| GRDN | Guardian Pharmacy Services | $1.45B | $351.77M |
| PGNY | Progyny | $1.29B | $350.51M |
| OMCL | Omnicell | $1.18B | $312.21M |
| TXG | 10x Genomics | $642.82M | $151.04M |
| CERT | Certara | $418.84M | $80.45M |
| OMDA | Omada Health | $260.21M | $87.83M |
| SDGR | Schrödinger | $255.87M | $58.89M |
| NUVB | Nuvation Bio | $62.90M | $31.69M |
| JANX | Janux Therapeutics | $10.00M | $10.27M |
| SION | Sionna Therapeutics | - | - |